chemical structure of thiopental sodium
Find information on thousands of medical conditions and prescription drugs.

Thiopental sodium

Sodium thiopental also called Sodium Pentothal (a trademark of Abbott Laboratories), thiopental, thiopentone sodium, or trapanal is a rapid-onset, short-acting barbiturate general anesthetic. more...

Home
Diseases
Medicines
A
B
C
D
E
F
G
H
I
J
K
L
M
N
O
P
Q
R
S
T
Oxytetracycline
Phentermine
Tacrine
Tacrolimus
Tagamet
Talbutal
Talohexal
Talwin
Tambocor
Tamiflu
Tamoxifen
Tamsulosin
Tao
Tarka
Taurine
Taxol
Taxotere
Tazarotene
Tazobactam
Tazorac
Tegretol
Teicoplanin
Telmisartan
Temazepam
Temocillin
Temodar
Temodar
Temozolomide
Tenex
Teniposide
Tenoretic
Tenormin
Tenuate
Terazosin
Terbinafine
Terbutaline
Terconazole
Terfenadine
Teriparatide
Terlipressin
Tessalon
Testosterone
Tetrabenazine
Tetracaine
Tetracycline
Tetramethrin
Thalidomide
Theo-24
Theobid
Theochron
Theoclear
Theolair
Theophyl
Theophyl
Theostat 80
Theovent
Thiamine
Thiomersal
Thiopental sodium
Thioridazine
Thorazine
Thyroglobulin
Tiagabine
Tianeptine
Tiazac
Ticarcillin
Ticlopidine
Tikosyn
Tiletamine
Timolol
Timoptic
Tinidazole
Tioconazole
Tirapazamine
Tizanidine
TobraDex
Tobramycin
Tofranil
Tolazamide
Tolazoline
Tolbutamide
Tolcapone
Tolnaftate
Tolterodine
Tomoxetine
Topamax
Topicort
Topiramate
Tora
Toradol
Toremifene
Tracleer
Tramadol
Trandate
Tranexamic acid
Tranxene
Tranylcypromine
Trastuzumab
Trazodone
Trenbolone
Trental
Trest
Tretinoin
Triacetin
Triad
Triamcinolone
Triamcinolone hexacetonide
Triamterene
Triazolam
Triclabendazole
Triclosan
Tricor
Trifluoperazine
Trilafon
Trileptal
Trimetazidine
Trimethoprim
Trimipramine
Trimox
Triprolidine
Triptorelin
Tritec
Trizivir
Troglitazone
Tromantadine
Trovafloxacin
Tubocurarine chloride
Tussionex
Tylenol
Tyrosine
U
V
W
X
Y
Z

Barbiturates

Barbiturates are a class of drugs that act on the GABAa receptor in the brain and spinal cord. The GABAa receptor is an inhibitory channel which decreases neuronal activity. Barbiturates have anesethetic, sedative, and hypnotic properties.

Uses

Thiopental is an ultra-short acting barbiturate and is most commonly used in the induction phase of general anaesthesia. Following intravenous injection the drug rapidly reaches the brain and causes unconsciouness within 30-45 seconds. At one minute, the drug attains a peak concentration of about 60% of the total dose in the brain. Thereafter, the drug distributes to the rest of the body and in about 5 minutes the concentration is low enough in the brain such that consciouness returns. Because of its pharmacokinetics, thiopental is never used for the maintence of anesthesia in surgical procedures. Maintainence of anesthesia is maintained by the inhaled anesthetics/flourinated hydrocarbons. This class of drugs has an extremely rapid elimination such that stopping the inhaled anesthetics will allow rapid return of consciousness. Thiopental would have to be given in large amounts to maintain an anesthetic plane, and because of its 11.5-26 hour half-life, consciousness would take a long time to return. In addition, the rapid redistribution of the drug out of the brain would make it very difficult to maintain appropriate anesthesia.

In addition to anesthesia induction, thiopental can be used for induction of medical comas. This is because the drug's half-life is much longer. Simply put, a large dose of the drug is given such that the distributive phase has a high enough concentration to maintain anesthesia. Patients with brain swelling, causing elevation of the intracranial pressure, either secondary to trauma or following surgery may benefit from this drug. Thiopental, and the barbiturate class of drugs, decreases neuronal activity and therefore decreases the production of osmotically active metabolites which in turn decreases swelling. Patients with significant swelling have improved outcomes following the induction of coma. Reportedly, thiopental has ben shown to be superior to pentobarbital in reducing intracranial pressure.

Along with pancuronium bromide and potassium chloride, thiopental is used in some states of the US to execute prisoners by lethal injection. A megadose is given which places the patient into a rapidly induced coma and maintains coma for about 55-130 hours. In the Netherlands, it is used to cause death after the induction of a coma by barbiturates.

It is still used in some places as a truth serum, recently used during the interrogation of Abu Faraj al-Libbi. in Pakistan and Abu Salem in India.

Read more at Wikipedia.org


[List your site here Free!]


Changes in hemodynamics during isoflurane and propofol anesthesia: a comparison study
From Neurological Research, 6/1/05 by De Cosmo, G

Objectives: Volatile anesthetics are thought to impair cerebral autoregulation more than i.v. anesthetics. However, few comparative studies have been carried out in humans. The aim of our study was to evaluate the differences in cerebral hemodynamic changes after introduction of isoflurane (a volatile anesthetic) and propofol (an i.v. anesthetic).

Methods: Eighteen consecutive patients submitted to laparoscopic cholecystectomy were selected. After the induction, anesthesia was maintained by isoflurane (one minimum alveolar anesthetic concentration) during the first part of the surgical operation, and then by propofol (5 mg/kg/hour i.v.). Ventilation was adjusted to maintain a constant end-tidal CO2. Middle artery flow velocity was assessed by means of transcranial Doppler ultrasonography. Arterial blood pressure, heart rate (HR), capnometry, pulse oxymetry, inspired fraction of O2, and body temperature, were monitored.

Results: Cerebral artery velocity, HR, and mean arterial pressure all significantly increased from baseline after the introduction of isoflurane (p

Conclusions: Propofol but not isoflurane decreased cerebral blood velocity thus restoring cerebral autoregulation and the coupling between cerebral blood flow and cerebral metabolism. [Neurol Res 2005; 27: 433-435]

Keywords: Cerebral blood flow; isoflurane; intravenous anesthetic; propofol; transcranical Doppler ultrasonography

INTRODUCTION

In physiological conditions, the brain has the capability of regulating cerebral blood flow to maintain a constant perfusion, regardless of blood pressure changes. This mechanism, named cerebral blood flow autoregulation, protects the brain from dangerous oscillations in systemic blood pressure1. Autoregulation is a sensitive mechanism that could be impaired in some pathological conditions, such as head injury, cerebral vascular diseases, and mass occupying lesions1"3.

General anesthesia can affect cerebral blood flow autoregulation as well4. Patients with an abated cerebral blood flow autoregulation, show an increased risk of developing cerebral hyperemia or intracranial hypertension during general anesthesia. Therefore, for these patients, the use of an anesthetic that does not further impair cerebral blood flow autoregulation would be advisable.

Evidence indicates that volatile anesthetics impair autoregulation to a greater extent than i.v. anesthetics5-9. However, so far only a few studies comparing the use of volatile and i.v. anesthetics have been carried out in humans10-13.

The aim of our study was to compare the cerebral blood flow modifications with the introduction first of isoflurane (a volatile anesthetic), then of propofol (an i.v. anesthetic), after the anesthetic induction was obtained by sodium thiopental and fentanyl.

MATERIALS AND METHODS

Eighteen patients (eleven females and seven males, mean age 52, range 38-65) scheduled to undergo Iaparoscopic cholecystecomy, were selected for our study, after they had signed informed consent (Tables 1 and 2). All of them were in good physical condition (ASA 1-11). The exclusion criteria included the presence either of cerebral, pulmonary, cardiac, cerebral vascular diseases, or of vasoactive drug therapy. After premedication with diazepam (8-10 mg per os), anesthetic induction was carried out with sodium thiopental (4 mg/kg) and fentanyl (5 µg/kg), followed by vecuronium bromide (0.1 mg/kg) to facilitate the intubation. During the first part of the surgical procedure, anesthesia was maintained by isoflurane 1 MAC (minimum alveolar anesthetic concentration). Isoflurane was changed to propofol, 30 minutes after intubation. The change to propofol was carried out by interruption of isoflurane, while starting an i.v. 10 mg/kg/hour infusion of propofol, which was kept constant for 15 minutes. The propofol infusion was then gradually reduced to 5 mg/kg/hour during the following 15 minutes, and so maintained until the end of the surgical procedure. Fentanyl (2 µg/kg) and vecuronium bromide (0.02 mg/kg) were added when necessary. Ventilation was adjusted to keep the end-tidal CO2 partial pressure (ETCO^sub 2^) between 28 and 39 mmHg. Standard anesthetic monitoring, including arterial blood pressure, heart rate (HR), capnometry, pulse oxymetry, inspired and expired isoflurane concentration, inspired fraction of O2, body temperature, was performed.

Measurement of mean arterial blood velocity (MFV) was obtained by isonating the right middle cerebral artery (MCA) using a 2-mHz pulsed wave probe (Multiplan Dop T, DWL GmnH, Germany), according to the method described by Aaslid14. Briefly, the MCA was isonated through the temporal bone above the zygomatic arch. The Doppler signals were measured at a depth of 50-60 mm, to provide the highest mean flow velocity. The probe was secured to the patient's head by means of special headgear in a position allowing for continuous monitoring of MFV.

The values of ETCO^sub 2^, mean arterial pressure (MAP), HR, and MFV were recorded four times during our study: at baseline (before anesthesia induction), after intubation, during isoflurane anesthesia (1 MAC), and finally during propofol anesthesia (5 mg/kg/hour).

A f-test for paired samples was used to analyze the data. A p value of

RESULTS

The data are summarized in TaWe 2. The mean duration of surgery was 134 minutes, ranging from 75 to 165 minutes. No significant variations in ETCO^sub 2^ were observed during our study. MAP and HR significantly increased from baseline values after isoflurane and propofol introduction (p

DISCUSSION

All of the patients enrolled in our study were scheduled to undergo laparoscopic surgery because in a precedent study we showed that PCO^sub 2^ intra-peritoneal insufflation did not cause CBF variations15.

Transcranial Doppler is a non-invasive and reliable method to assess blood flow velocity in the basal cerebral artery16. MFV in the MCA and CBF poorly correlate, but changes in MFV are proportional to changes in CBF17'18.

In our study MFV, but not MAP and HR, was significantly higher during isoflurane anesthesia than during propofol anesthesia. ETCO^sub 2^ was kept to baseline values during the whole surgical procedure and therefore the difference in MFV could not be ascribed to arterial blood CO2 pressure variations. Instead, isoflurane could have increased CBF by means of an induction of the cerebral resistance vessels vasodilatation, thus impairing cerebral blood flow autoregulation. Isoflurane has indeed a direct cerebrovasodilatatory effect on cerebral blood vessels and produces vasodilatation regardless of the cerebral metabolism reduction19'20. Moreover, vasodilatation produces an important narrowing of the cerebral autoregulation range1. In contrast, propofol preserves the coupling between CBF and cerebral metabolism, decreasing metabolism and indirectly producing vasoconstriction21. The increase in MFV, observed after the introduction of isoflurane, was presumably due to both the MAP increase and the cerebral autoregulation impairment. The propofol introduction instead preserved the cerebral autoregulation and re-established the coupling between CBF and cerebral metabolism, thus reducing MFV.

CONCLUSIONS

MFV is significantly higher during isoflurane anesthesia than during propofol anesthesia. This difference is probably due to the cerebral autoregulation impairment produced by isoflurane. The risk of inducing cerebral hyperemia or intracranial hypertension is reasonably low for healthy patients but could be particularly high for those patients who have a reduced cerebral autoregulation like those suffering from a cerebrovascular disease or a head injury. In such patients, use of the i.v. anesthetic propofol would be more advisable then the use of the volatile anesthetic (isoflurane).

REFERENCES

1 Paulson OB, Strandgaard S, Edvinsson L. Cerebral autoregulation. Cerebrovasc Brain Metab Rev 1990; 2: 161-192

2 Agnoli A, Fieschi C, Bozzao L, et al. Autoregulation of cerebral blood flow: Studies during drug induced hypertension in normal subjects and in patients with cerebral vascular diseases. Circulation 1968; 38: 800-812

3 Czosnyka M, Smielewski P, Piechnik S, et al. Cerebral autoregulation following head injury. J Neurosurg 2001; 95: 756-763

4 Smith AL, Neigh JL, Huffman JC, et al. Effect of general anesthesia on autoregulation of cerebral blood flow in man. J App Physiol 1970; 29: 665-669

5 Malta BF, Lam AM, Strebel S, et al. Cerebral pressure autoregulation and carbon dioxide reactivity during propofol-induced EEC suppression. Br J Anaesth 1995; 74: 159-163

6 Bedforth NM, Hardman JC, Nathanson MH. Cerebral hemodynamic response to the introduction of desflurane: A comparison with sevoflurane. Anesth Analg2000; 91: 152-155

7 Bedforth NM, Girling KJ, Skinner HJ, et al. Effects of desflurane on cerebral autoregulation. Br J Anaesth 2001; 87: 193-197

8 Olsen KS, Henriksen L, Owen-Falkenberg A, et al. Effect of 1 or 2 MAC isoflurane with or without ketanserin on cerebral blood flow autoregulation in man. Br J Anaesth 1994; 72: 66-71

9 Harrison JM, Girling KJ, Mahajan RP. Effects of propofol and nitrous oxide on middle cerebral artery flow velocity and cerebral autoregulation. Anaesthesia 2002; 57: 27-32

10 Strebel S, Lam AM, Malta B, et al. Dynamic and static cerebral autoregulation during isoflurane, desflurane, and propofol anesthesia. Anesthesiology 1995; 83: 66-76

11 McCulloch TJ, Visco E, Lam AM. Graded hypercapnia and cerebral autoregulation during sevoflurane or propofol anesthesia. Anesthesiology 2000; 93: 1205-1209

12 Petersen KD, Landsfeldt U, Cold GE, et al. lntracranial pressure and cerebral haemodynamic in patients with cerebral tumors: A randomized prospective study of patients subjected to craniotomy in propofol-fentanyl, isoflurane-fentanyl, or sevoflurane-fentanyl anesthesia. Anesthesiology 2003; 98: 329-336

13 Holzer A, Winter W, Greher M, et al. A comparison of propofol and sevoflurane anaesthesia: Effects on aortic blood flow velocity and middle cerebral artery blood flow velocity. Anaesthesia 2003; 58: 217-222

14 Aaslid R, Markwalder TH, Normes H. Non invasive transcranial Doppler ultrasound recording of flow velocity in basal cerebral arteries. J Neurosurg 1982; 57: 769-774

15 De Cosmo G, lannace E, Primieri P, et al. Changes in cerebral hemodynamics during laparoscopic cholecystectomy. Neurol Res 1999; 21: 658-660

16 Aaslid R, Markwalder TM, Nornes H. Noninvasive transcranial Doppler ultrasound recording of flow velocity in basal cerebral arteries. Neurosurgery 1982; 57: 769-774

17 Bishop CC, Powell S, Rutt D, et al. Transcranial Doppler measurement of middle cerebral artery blood flow velocity: A validation study. Stroke 1986; 17: 913-915

18 Newell DW, Aaslid R, Lam A, et al. Comparison of flow and velocity during dynamic autoregulation testing in humans. Stroke 1994; 25: 793-797

19 Malta BF, Heath KJ, Tipping K, et al. Direct cerebral vasodilatory effects of sevoflurane and isoflurane. Anesthesiology 1999; 91: 677-680

20 Malta BF, Mayberg TS, Arthur M. Direct cerebrovasodilatory effects of halothane, isoflurane and desflurane during propofolinduced isoelectric electroencephalogram in humans. Anesthesiology 1995; 83: 980-985

21 Artru AA, Shapira Y, Bowdle TA. Electroencephalogram, cerebral metabolic and vascular responses to propofol anesthesia in dogs. J Neurosurg Anesth 1992; 4: 99-109

G. De Cosmo*, I. Cancell[dagger], A. Adduci*, G. Merlino[dagger], P. Aceto* and M. Valente[dagger]

[dagger] Neurological Clinic, DPMSC University of Udine, Italy Piazzale Rodolone 2, 33100 Cemona Del Friuli (UD), Italy

* lnstitute of Anesthesiology and Reanimation, Catholic University of Rome, Italy Largo A. Cemelli, 00168 Roma, Italy

Correspondence and reprint requests to: Mariarosaria Valente, Piazzale Rodolone 2, 33013 Gemona Del Friuli (UD), Italy, [mariarosaria. valente@uniud.it] Accepted for publication October 2004

Copyright Maney Publishing Jun 2005
Provided by ProQuest Information and Learning Company. All rights Reserved

Return to Thiopental sodium
Home Contact Resources Exchange Links ebay